![Koji Kitami](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Koji Kitami
Directeur/Membre du Conseil chez Site Quality Co., Ltd.
Provenance du réseau au premier degré de Koji Kitami
Entité | Type d'entité | Industrie | |
---|---|---|---|
Site Quality Co., Ltd.
![]() Site Quality Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Site Quality Co., Ltd. provides consulting services to medical institutions. It offers informed consent acquisition assistance, patient schedule administration, hospital data collection management, time monitoring, case report form preparation support, document creation assistance, and clinical research coordination. The company was founded in November 2003 and is headquartered in Hachioji, Japan.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
MediBIC Pharma
4
| Subsidiary | 4 | |
Private Company | Miscellaneous Commercial Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Koji Kitami via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
EVOLUTION JAPAN Co., Ltd.
![]() EVOLUTION JAPAN Co., Ltd. Investment Banks/BrokersFinance EVOLUTION JAPAN Co., Ltd. engages in the business services industry with focus on commodity trading investments. It also operates in purchase and sale listed products; trading consignment business; collection, analysis, and provision of domestic, foreign, economy, and product related information; handling of precious metals and gold coins; and financial instruments brokerage. The company was founded in 1971 and is headquartered in Tokyo, Japan. | Investment Banks/Brokers | Chairman | |
REVOLUTION CO., LTD. | Homebuilding | President | |
Disclosure, Inc.
![]() Disclosure, Inc. Commercial Printing/FormsCommercial Services Disclosure, Inc. is based in Bethesda, MD. Part of The Nielsen Company (US) LLC, Disclosure, Inc. is a company that provides publishing services. The CEO of the company is Kazuharu Tomioka. | Commercial Printing/Forms | Chief Executive Officer | |
Baring Securities Ltd.
![]() Baring Securities Ltd. Investment Banks/BrokersFinance Part of ING Groep NV, Baring Securities Ltd. is a Chinese company that provides securities brokerage services. The company is based in Hong Kong, Hong Kong. | Investment Banks/Brokers | Director/Board Member | |
JAPAN ASSET MARKETING CO., LTD. | Real Estate Development | Director/Board Member | |
Princeton University | College/University | Undergraduate Degree | |
Waseda University | College/University | Undergraduate Degree | |
London School of Economics & Political Science | College/University | Undergraduate Degree | |
Seikei University | College/University | Graduate Degree | |
Frontier Consulting Japan KK | Chief Executive Officer | ||
MediBIC KK
![]() MediBIC KK Miscellaneous Commercial ServicesCommercial Services Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member President | |
Generation Group KK | Director/Board Member | ||
BIO-Business Solutions | Director/Board Member | ||
Animal Stemcell KK
![]() Animal Stemcell KK BiotechnologyHealth Technology Part of MediBIC Group, Animal Stemcell KK engages in research and development, and production of animal stem cells and regenerative medicine. The company is based in Koganei, Japan. Animal Stemcell KK was acquired by MediBIC Group from Resort & Medical Co., Ltd. on October 08, 2013 for $3.02 million. | Biotechnology | Director/Board Member Director/Board Member President | |
QC Asset, Inc. | Director/Board Member | ||
Ambicion KK
![]() Ambicion KK Miscellaneous Commercial ServicesCommercial Services Ambicion KK is a company based in Tokyo, Japan that focuses on developing novel cancer immunotherapies and allergy treatments. The Japanese company specializes in creating drugs that target NKT cells and promoting cancer immunotherapy that targets NKT cells, which is not covered by insurance. The company was founded in 2015, and the CEO is Kenji Suzuki. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
Japon | 13 |
Etats-Unis | 3 |
Hong Kong | 2 |
Royaume-Uni | 2 |
Sectorielle
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 4 |
Consumer Durables | 2 |
Health Technology | 2 |
Opérationnelle
Director/Board Member | 29 |
President | 6 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 3 |
Chief Executive Officer | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Koji Kitami
- Connexions Sociétés